Antimicrobial stewardship challenges in recurrent hospital-acquired pneumonia: A 4-year case report of multi-drug-resistant pathogens after upper-gastrointestinal reconstruction
Medicinska istrazivanja · 2026 · (00) · 41-41
DOI: 10.5937/medi0-70909 ↗Abstract
Background: Recurrent hospital-acquired pneumonia (HAP) after complex upper-gastrointestinal (upper-GI) reconstruction poses major antimicrobial stewardship challenges, particularly when multidrug-resistant (MDR) pathogens dominate the microbiological spectrum. Case presentation: We report a 35-year-old woman with hydrochloric acid ingestion requiring total gastrectomy with esophagectomy, cervical esophagostoma, and subcutaneous antethoracic ileocoloplasty with high pharyngoileal anastomosis. Over four years (2022-2025), she experienced 16 radiologically and laboratory-documented episodes of pneumonia and 13 episodes with microbiologically isolated microorganisms across six surgical hospitalizations. Serial bronchoalveolar lavage and blood cultures yielded MRSA, MDR Serratia marcescens, MDR Klebsiella pneumoniae, MDR Pseudomonas aeruginosa, and MDR Stenotrophomonas maltophilia. Cumulative antibiotic exposure reached 235.67 defined daily doses (DDD), with 143 chest radiographs, 12 thoracic CTs, and 95 bronchoscopies with BAL during 271 days of hospitalization. Inflammatory markers (procalcitonin, CRP) peaked during septic relapses. Despite aggressive antimicrobial therapy and repeated surgical interventions, including tracheostomy, laryngotracheal resection, and right pneumonectomy, pneumonia recurred until definitive airway and digestive conduit stabilization were achieved. Following the last treated episode in April 2025 and subsequent fistula closure, the patient remained free of pulmonary inflammation for 15 months during outpatient follow-up. Conclusion: This case illustrates how anatomical disruption, aspiration risk, repeated healthcare exposure, and substantial antimicrobial use may act as potential selection pressures for MDR/XDR organisms in recurrent HAP. The findings emphasize the importance of explicit case definitions, careful distinction between infection and colonization, source control, and structured antimicrobial stewardship. It underscores the need for early source control, biomarker-guided antibiotic proper duration, and multidisciplinary coordination in similar patients to limit further resistance and improve outcomes.
EUVIMED